Clinical Trial Update: Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effects of dabigatran and phenprocoumon on ADP-induced platelet aggregation in patients with atrial fibrillation. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Marcumar (phenprocoumon)
• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED